Brighton Jones’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-18,317
Closed -$40.1K – 1417
2026
Q2
$40.1K Buy
+18,317
New +$54.1K ﹤0.01% 1374

Other funds holding CMPX

Brighton Jones's CMPX Position: Q3 2026 in Review

Brighton Jones sold out of Compass Therapeutics (CMPX) in Q3 2026, closing a stake of 18,317 shares — an estimated $40.1K sold.

Brighton Jones first reported a position in CMPX in Q2 2026 and held it in 1 quarter. The position peaked at $40.1K in Q2 2026. 129 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.

  • Brighton Jones reported no remaining Compass Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 18,317 Compass Therapeutics shares in Q3 2026, an estimated $40.1K.
  • Brighton Jones first reported a position in Compass Therapeutics in Q2 2026 and held it in 1 quarter.
  • Brighton Jones's Compass Therapeutics position peaked at $40.1K in Q2 2026.
  • 129 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.